dabl® News - dabl Clinical Trials

22 Sep 2021

Athens, Greece, Sept. 14, 2021 – European Society of Hypertension (ESH), the leading hypertension (HTN) society in Europe, presented an updated position paper on renal denervation (RDN) during the 8th pre-ESH congress satellite symposium in Athens, Greece from September 10-11, 2021 . The paper was recently published in the September issue of the Journal of Hypertension.

{...} click to continue

New Hypertension Core Lab partnership
15 Jul 2021

Hypertension affects a substantial part of the world’s population. Treatment options include lifestyle changes and drug-based therapies. Device-based therapies for hypertension are under development and used within the context of clinical studies and randomized controlled and sham-controlled trials. Research on device-based therapies for hypertension typically use ambulatory blood pressure monitoring (ABPM) as primary endpoint. Key […]

{...} click to continue

dabl’s quality meeting the highest standards
21 Oct 2020

Certification Europe issues ISO 9001:2015 Surveillance Assessment report and certificate to dabl Limited stating no issues of nonconformity were detected during the assessment and that dabl’s Quality Management System continues to satisfy the requirements of the company.

{...} click to continue